A revolutionary new test for the early detection of testicular cancer—the most common cancer among young men—is now available in the UK. Developed by Cambridge-based EDX Medical, the non-invasive “TC100”…
Harrow Expands Access to VEVYE® for Klarity-C Patients at $59 Per Bottle Harrow (Nasdaq: HROW), a leading eyecare pharmaceutical company in North America, has announced the expansion of its VEVYE®…
A recent survey by Croí, the Heart & Stroke Charity in Ireland, in collaboration with the Global Heart Hub (GHH), has uncovered a worrying lack of awareness about heart attack…
Five Good Friends, a leading Australian home care provider, has announced a major strategic investment from TPG, a global alternative asset management firm. The partnership will support the company’s continued…
Teladoc Health Unveils Next-Generation Cardiometabolic Health Program to Combat Chronic Disease Teladoc Health (NYSE: TDOC), a global leader in virtual healthcare, has announced the launch of its next-generation Cardiometabolic Health…
Study Finds K Health’s AI Recommendations Match Doctors’ in Accuracy K Health, a leading AI-driven primary care platform, recently revealed exciting results from a novel study demonstrating that its AI-powered…
ENHERTU® Approved in the EU for HER2-Low Metastatic Breast Cancer Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/Nasdaq: AZN) announced the approval of ENHERTU® (trastuzumab deruxtecan) in the European Union (EU)…
eClinical Solutions: AI Adoption and Risk-Based Strategies in 2025 Clinical Trials eClinical Solutions LLC, a global provider of digital clinical software and services, has unveiled key insights from its 2025…
Saskatchewan Expands Public Coverage for Dexcom CGM Systems The Government of Saskatchewan has officially expanded its public coverage for continuous glucose monitoring (CGM) systems, a decision that is set to…
Predictmedix AI Closes $100,000 Third Tranche and Launches Smart Health AI Stations Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP), a leader in AI-powered health screening solutions, is excited…
Siemens Healthineers’ Antithrombin Blood Test FDA Cleared as Companion Diagnostic for Sanofi’s Qfitlia Hemophilia Therapy Siemens Healthineers announced that its Innovance Antithrombin assay has received FDA clearance for a new…
Cell Therapy for Male Urethral Stricture: BEES-HAUS Trial at Edogawa Hospital, Japan Urethral stricture, a condition that affects men across all age groups but becomes more prevalent after the age…